Intranasal anti-convulsive compositions and methods
OwnerRobert Orrinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerRobert Orrinventor
Estimating the term…
Contemplated pharmaceutical compositions comprise a benzodiazepine anti-convulsive compound for intranasal administration in a single phase, multi-component solvent system with water content of at least 15 vol % and a benzodiazepine concentration of at least 30 mg/ml. It is noted that contrary to common expectation, the concentration of the anti-convulsive compound was increased by increasing water content in the multi-component solvent. Moreover, the anti-convulsive compound remained chemically stable and substantially completely dissolved over large periods of time. Thus, stable and highly concentrated spray formulations for intranasal administration could be prepared having sufficiently high concentrations of the anti-convulsive compounds that now allow single spray administration to achieve clinically relevant dosages.
A method of increasing a concentration of a diazepam in an aqueous, single phase, multi-component solvent system, comprising:
An aqueous pharmaceutical composition formulated for intranasal administration in atomized spray form having an average droplet size between 20 and 150 micron, the composition comprising:
Dependencies are inferred from the claim text.